Bupivacaine Injection Market

Bupivacaine is used to prevent or relieve?pain, but it will not put you to sleep. Bupivacaine Injection is used during or after surgery to relieve pain. It can also be used to make childbirth less painful.

Bupivacaine Injection Market contains market size and forecasts of Bupivacaine Injection in global, including the following market information:

Global Bupivacaine Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bupivacaine Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bupivacaine Injection companies in 2021 (%)

The global Bupivacaine Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.0025 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bupivacaine Injection include Pfizer, AuroMedics, Fresenius Kabi, Baxter, Areva, SteriMax, AstraZeneca, Shanghai Harvest Pharmaceutical and Zhaohui Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Bupivacaine Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bupivacaine Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Injection Market Segment Percentages, by Type, 2021 (%)

• 0.0025
• 0.005
• 0.0075

Global Bupivacaine Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Bupivacaine Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Bupivacaine Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Bupivacaine Injection revenues share in global market, 2021 (%)
• Key companies Bupivacaine Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Bupivacaine Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• AuroMedics
• Fresenius Kabi
• Baxter
• Areva
• SteriMax
• AstraZeneca
• Shanghai Harvest Pharmaceutical
• Zhaohui Pharmaceutical
• Shandong Hualu Pharmaceutical